Suppr超能文献

腹内压升高和容量扩张对大鼠肾功能的影响。

Effects of increased intra-abdominal pressure and volume expansion on renal function in the rat.

作者信息

Lindström Pernilla, Wadström Jonas, Ollerstam Anna, Johnsson Cecilia, Persson A Erik G

机构信息

Division of Integrative Physiology, Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.

出版信息

Nephrol Dial Transplant. 2003 Nov;18(11):2269-77. doi: 10.1093/ndt/gfg362.

Abstract

BACKGROUND

The effects of increased intra-abdominal pressure (IAP) and volume expansion on renal function in the rat were studied to gain more knowledge of the oliguria seen during laparoscopic procedures and to reduce the detrimental renal effects of IAP.

METHODS

IAP was elevated to 5 or 10 mmHg by insufflation of CO(2) and maintained for 2 h in anaesthetized and mechanically ventilated rats. Rats with normal IAP served as controls. An angiotensin II receptor I antagonist, candesartan, was given as a bolus injection and a 5% volume expansion was achieved by i.v. saline infusion. An angiotensin-converting enzyme (ACE) inhibitor was also given. Renal parameters were the glomerular filtration rate (GFR), urine production, the urinary concentrations of sodium and potassium and the osmolality in the urine. The arterial acid-base balance and blood pressure were also monitored.

RESULTS

The GFR deteriorated by 70% during pneumoperitoneum (PP) of 10 mmHg. There was a dramatic drop in sodium excretion (88-97%). With candesartan and elevated IAP, there was a drop in mean arterial pressure (from 90 to 55 mmHg) and the negative renal effects were very pronounced. Renal function was better preserved during elevated IAP in combination with volume expansion.

CONCLUSIONS

Capnoperitoneum suppresses renal function, especially in combination with angiotensin II receptor 1 blockade and ACE inhibition. Volume expansion reduces the deleterious effects of PP on renal function during elevated IAP. The results suggest that patients should not be given pharmaceuticals blocking the renin-angiotensin-aldosterone system prior to procedures that may increase IAP. It may be beneficial, however, to reduce angiotensin II tension by volume expansion.

摘要

背景

研究腹内压(IAP)升高和容量扩张对大鼠肾功能的影响,以进一步了解腹腔镜手术期间出现的少尿情况,并减少IAP对肾脏的有害影响。

方法

通过向麻醉并机械通气的大鼠腹腔内注入二氧化碳使IAP升高至5或10 mmHg,并维持2小时。IAP正常的大鼠作为对照。静脉推注血管紧张素II受体1拮抗剂坎地沙坦,并通过静脉输注生理盐水实现5%的容量扩张。同时给予血管紧张素转换酶(ACE)抑制剂。肾脏参数包括肾小球滤过率(GFR)、尿量、尿钠和尿钾浓度以及尿渗透压。还监测动脉酸碱平衡和血压。

结果

在10 mmHg气腹(PP)期间,GFR恶化了70%。钠排泄急剧下降(88 - [此处原文可能有误,推测为98]%)。使用坎地沙坦且IAP升高时,平均动脉压下降(从90 mmHg降至55 mmHg),对肾脏的负面影响非常明显。在IAP升高并伴有容量扩张时,肾功能得到更好的保留。

结论

气腹会抑制肾功能,特别是在联合使用血管紧张素II受体1阻滞剂和ACE抑制剂时。容量扩张可减少IAP升高期间PP对肾功能的有害影响。结果表明,在可能增加IAP的手术前,不应给予患者阻断肾素 - 血管紧张素 - 醛固酮系统的药物。然而,通过容量扩张降低血管紧张素II张力可能有益。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验